Geron | GERN - Capital Ordinário





Capital Ordinário Alterar Data
Amgen USD 540M 1000K 2026-03
Bio Techne USD 156.45M 703K 2026-03
Cassava Sciences USD 48.31M 0 2026-03
Cytokinetics USD 124.43M 2.17M 2026-03
Esperion Therapeutics USD 245.22M 39.79M 2025-12
Exelixis USD 253.7M 8.78M 2026-03
Genmab DKK 61.62M 52K 2025-12
Geron USD 640.9M 2.54M 2026-03
Gilead Sciences USD 1.24B 1000K 2026-03
Incyte USD 199.95M 1.49M 2026-03
MacroGenics USD 63.56M 241K 2026-03
Novartis USD 1.91B 60K 2026-03
Novavax USD 162.58M 106K 2025-12